Filings a company makes when something has gone wrong, or is about to: a missed reporting deadline (NT 10-K/Q), a delisting from its exchange (Form 25), a deregistration that ends SEC reporting altogether (Form 15), or an insider's notice of intent to sell restricted stock (Form 144). Any one can be routine — Form 144s are filed constantly, and a late filing is sometimes just a late filing — so what is worth reading here is the pattern and the timing.
70,822 shares · $425,000 · via MDB Capital, · Board Member
ENDRA Life Science Inc.’s (the “Company”) quarterly report on Form 10-Q for the quarter ended September 30, 2024 (the “Form 10-Q”) cannot be filed by the prescribed due date without unreasonable ef...
2 more red-flag filings behind a free account
See every red-flag filing ENDRA Life Sciences Inc has made, with the filing behind each one.
Sign up freeLoading...
